UBS Group restated their neutral rating on shares of Spire Healthcare Group (LON:SPI) in a report published on Monday morning, Digital Look reports. They currently have a GBX 120 ($1.57) target price on the stock.
Several other research analysts have also recently weighed in on the company. Liberum Capital restated a hold rating on shares of Spire Healthcare Group in a research note on Monday, August 5th. Barclays reaffirmed an underweight rating and issued a GBX 115 ($1.50) price objective on shares of Spire Healthcare Group in a report on Friday, August 9th. Royal Bank of Canada reaffirmed an outperform rating and issued a GBX 149 ($1.95) price objective on shares of Spire Healthcare Group in a report on Monday, September 9th. Finally, Peel Hunt raised Spire Healthcare Group to an add rating and set a GBX 155 ($2.03) price objective for the company in a report on Monday. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company. The company presently has a consensus rating of Hold and an average price target of GBX 130.44 ($1.70).
SPI stock opened at GBX 115 ($1.50) on Monday. Spire Healthcare Group has a 1-year low of GBX 95.25 ($1.24) and a 1-year high of GBX 176 ($2.30). The business has a fifty day moving average price of GBX 106.29 and a 200-day moving average price of GBX 121.25. The company has a debt-to-equity ratio of 48.52, a current ratio of 1.44 and a quick ratio of 0.95. The stock has a market capitalization of $461.24 million and a P/E ratio of 41.07.
The company also recently disclosed a dividend, which will be paid on Tuesday, December 10th. Investors of record on Thursday, November 14th will be issued a GBX 1.30 ($0.02) dividend. This represents a dividend yield of 1.07%. The ex-dividend date of this dividend is Thursday, November 14th. Spire Healthcare Group’s payout ratio is currently 1.43%.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Featured Article: What is the Fibonacci sequence?
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.